Back to MLTX
D. E. Shaw & Co., Inc. MLTX Position History
MoonLake Immunotherapeutics • Healthcare
Quarters held
7
Latest value
$1.7M
Q3 2026
Peak value
$65.5M
First seen
Q4 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2023 | $7.8M |
| Q3 2025 | $662K |
| Q4 2025 | $32.7M |
| Q1 2026 | $44.6M |
| Q2 2026 | $65.5M |
| Q3 2026 | $39.1M |
| Q3 2026 | $1.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $1.7M | 147.2K | — | — |
| Q3 2026 | $39.1M | 3.34M | — | — |
| Q2 2026 | $65.5M | 3.37M | — | — |
| Q1 2026 | $44.6M | 2.39M | — | — |
| Q4 2025 | $32.7M | 2.48M | — | — |
| Q3 2025 | $662K | 92.3K | — | — |
| Q4 2023 | $7.8M | 128.7K | — | — |
Other funds holding MLTX
$311.5M
$298.3M
$260.3M
$256.4M
$192.9M
$191.2M
$187.2M
$182.6M